Eli Lilly’s Orforglipron Poised to Shake Up China’s Diabetes and Obesity Market

‼️ 💊 🇨🇳 BREAKING: Eli Lilly’s orforglipron type-2 diabetes and obesity pill could launch in China as soon as later this year, an executive at the U.S. drugmaker told Reuters

Leave a comment